Serum fatty acids and the risk of coronary heart disease - PubMed (original) (raw)
Clinical Trial
Serum fatty acids and the risk of coronary heart disease
J A Simon et al. Am J Epidemiol. 1995.
Abstract
To examine the relation between serum fatty acids and coronary heart disease (CHD), the authors conducted a nested case-control study of 94 men with incident CHD and 94 men without incident CHD who were enrolled in the Usual Care group of the Multiple Risk Factor Intervention Trial between December 1973 and February 1976. After confirming the stability of the stored serum samples, the authors measured serum fatty acid levels by gas-liquid chromatography and examined their association with CHD. In all multivariate models, levels of the cholesterol ester saturated fatty acid palmitic acid (16:0) were directly associated with CHD risk (standardized odds ratio = 1.68; 95% confidence interval 1.10-2.55 in the model that adjusted for total plasma cholesterol level). Levels of the phospholipid omega-3 fatty acid docosapentaenoic acid (22:5) were inversely associated with CHD risk in the two multivariate models that controlled for the effects of total plasma cholesterol level or high density lipoprotein cholesterol to total plasma cholesterol ratio (standardized odds ratio = 0.58; 95% confidence interval 0.38-0.89 in the first model that controlled for total plasma cholesterol level). In contrast to the first two multivariate models, levels of the docosahexaenoic acid (22:6) were inversely associated with CHD risk in a third multivariate model that controlled for the effects of high density lipoprotein cholesterol to low density lipoprotein cholesterol ratio (standardized odds ratio = 0.57; 95% confidence interval 0.36-0.90). These findings are consistent with other evidence indicating that saturated fatty acids are directly correlated with CHD and that omega-3 polyunsaturated fatty acids are inversely correlated with CHD. Because these associations were present after adjustment for blood lipid levels, other mechanisms, such as a direct effect on blood clotting, may be involved.
Similar articles
- Plasma levels of n-3 fatty acids and risk of coronary heart disease among Japanese: The Japan Public Health Center-based (JPHC) study.
Hamazaki K, Iso H, Eshak ES, Ikehara S, Ikeda A, Iwasaki M, Hamazaki T, Tsugane S; JPHC Study Group. Hamazaki K, et al. Atherosclerosis. 2018 May;272:226-232. doi: 10.1016/j.atherosclerosis.2017.12.004. Epub 2017 Dec 8. Atherosclerosis. 2018. PMID: 29277442 - Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study.
Khaw KT, Friesen MD, Riboli E, Luben R, Wareham N. Khaw KT, et al. PLoS Med. 2012;9(7):e1001255. doi: 10.1371/journal.pmed.1001255. Epub 2012 Jul 3. PLoS Med. 2012. PMID: 22802735 Free PMC article. - Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.
Joshi PH, Khokhar AA, Massaro JM, Lirette ST, Griswold ME, Martin SS, Blaha MJ, Kulkarni KR, Correa A, D'Agostino RB Sr, Jones SR, Toth PP; Lipoprotein Investigators Collaborative (LIC) Study Group. Joshi PH, et al. J Am Heart Assoc. 2016 Apr 29;5(5):e002765. doi: 10.1161/JAHA.115.002765. J Am Heart Assoc. 2016. PMID: 27130348 Free PMC article. - Diet and coronary heart disease.
Oliver MF. Oliver MF. Hum Nutr Clin Nutr. 1982;36(6):413-27. Hum Nutr Clin Nutr. 1982. PMID: 6298152 Review. - Serum fatty acids and coronary heart disease in Finnish populations.
Nikkari T. Nikkari T. Prog Lipid Res. 1986;25(1-4):437-50. doi: 10.1016/0163-7827(86)90089-5. Prog Lipid Res. 1986. PMID: 3321090 Review.
Cited by
- Quantitation of multiple sphingolipid classes using normal and reversed-phase LC-ESI-MS/MS: comparative profiling of two cell lines.
Masood MA, Rao RP, Acharya JK, Blonder J, Veenstra TD. Masood MA, et al. Lipids. 2012 Feb;47(2):209-26. doi: 10.1007/s11745-011-3633-2. Epub 2011 Nov 29. Lipids. 2012. PMID: 22124806 Free PMC article. - Correlation of omega-3 levels in serum phospholipid from 2053 human blood samples with key fatty acid ratios.
Holub BJ, Wlodek M, Rowe W, Piekarski J. Holub BJ, et al. Nutr J. 2009 Dec 24;8:58. doi: 10.1186/1475-2891-8-58. Nutr J. 2009. PMID: 20034401 Free PMC article. - Averting comfortable lifestyle crises.
Bilton R. Bilton R. Sci Prog. 2013;96(Pt 4):319-68. doi: 10.3184/003685013X13743292107915. Sci Prog. 2013. PMID: 24547668 Free PMC article. Review. - Plasma phospholipid fatty acid biomarkers of dietary fat quality and endogenous metabolism predict coronary heart disease risk: a nested case-control study within the Women's Health Initiative observational study.
Matthan NR, Ooi EM, Van Horn L, Neuhouser ML, Woodman R, Lichtenstein AH. Matthan NR, et al. J Am Heart Assoc. 2014 Aug 13;3(4):e000764. doi: 10.1161/JAHA.113.000764. J Am Heart Assoc. 2014. PMID: 25122663 Free PMC article. - Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
Wu JH, Lemaitre RN, Manichaikul A, Guan W, Tanaka T, Foy M, Kabagambe EK, Djousse L, Siscovick D, Fretts AM, Johnson C, King IB, Psaty BM, McKnight B, Rich SS, Chen YD, Nettleton JA, Tang W, Bandinelli S, Jacobs DR Jr, Browning BL, Laurie CC, Gu X, Tsai MY, Steffen LM, Ferrucci L, Fornage M, Mozaffarian D. Wu JH, et al. Circ Cardiovasc Genet. 2013 Apr;6(2):171-83. doi: 10.1161/CIRCGENETICS.112.964619. Epub 2013 Jan 29. Circ Cardiovasc Genet. 2013. PMID: 23362303 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources